Press release
Strong Growth Ahead: Hyperuricemia Drugs Market Size To Grow At Arecord 8.2% Cagr By 2029
Hyperuricemia Drugs Market
How Big Is the Hyperuricemia Drugs Market Size Expected to Be by 2034?
The hyperuricemia drugs market size is expected to grow from $4.75 billion in 2024 to $5.16 billion in 2025, with a CAGR of 8.5%. The growth is driven by the increasing prevalence of gout, limited treatment options, a growing elderly population, sedentary lifestyles, and rising awareness of hyperuricemia.
The hyperuricemia drugs market is expected to reach $7.07 billion in 2029, with a CAGR of 8.2%. Growth is attributed to rising chronic kidney disease rates, early diagnosis focus, personalized medicine demand, novel drug development, and higher healthcare expenditure. Trends include precision medicine focus, combination therapies, non-invasive treatments, drug safety emphasis, and pharmacogenomics advancements.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19517
What Are the Emerging Segments Within the Hyperuricemia Drugs Market?
The hyperuricemia drugsmarket covered in this report is segmented -
1) By Type: Asymptomatic Hyperuricemia, Symptomatic Hyperuricemia, Other Types
2) By Drugs: Nonsteroidal Anti-Inflammatory Drugs, Xanthine Oxidase Inhibitors, Selective Uric Acid Reabsorption Inhibitor (SURI), Uricosuric Agents, Other Drugs
3) By Diseases: Gout, Kidney Stone, Other Diseases
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Asymptomatic Hyperuricemia: Uric Acid Lowering Agents, Lifestyle Modification Supplements
2) By Symptomatic Hyperuricemia: Anti-Inflammatory Drugs, Uric Acid Inhibitors, Corticosteroids
3) By Other Types: Combination Therapy, Supportive Care Medications, Dietary Supplements
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19517&type=smp
What Long-Term Drivers Are Shaping Hyperuricemia Drugs Market Trends?
The rise in hyperuricemia and gout cases is contributing to the growth of the hyperuricemia drug market. These conditions, linked to elevated uric acid levels, are influenced by diet, genetics, and comorbidities such as obesity and diabetes. Medications for hyperuricemia help manage uric acid and prevent complications. A July 2024 study from The Lancet estimated 95.8 million people could be living with gout by 2050, with the condition being 3.26 times more common in males. This rising prevalence is driving the hyperuricemia drug market.
Who Are the Top Competitors in Key Hyperuricemia Drugs Market Segments?
Major companies operating in the hyperuricemia drugs market are Pfizer Inc., Merck & Co., Bayer AG, Sanofi SA, Myers Squibb Bristol Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline PLC, Roche Holdings Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceuticals, Regeneron Pharmaceuticals Inc., Teijin Pharma Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd., Kissei Pharmaceutical Co. Ltd., Himalaya Wellness Company, Fuji Yakuhin Co. Ltd.
What Hyperuricemia Drugs Market Trends Are Gaining Traction Across Different Segments?
Companies in the hyperuricemia drug market are focusing on innovative products like therapeutic equivalent generic versions to offer cost-effective alternatives and improve access to gout treatment. These generic medications match the active ingredients of brand-name drugs and provide the same clinical effect. In January 2024, Lupin, an India-based pharmaceutical company, received US approval for Febuxostat Tablets (40 mg and 80 mg) and Varenicline Tablets (0.5 mg and 1 mg), offering more affordable treatment options for hyperuricemia and smoking cessation.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/hyperuricemia-drugs-global-market-report
Which Regions Are Becoming Hubs for Hyperuricemia Drugs Market Innovation?
North America was the largest region in the hyperuricemia drugs market in 2024. The regions covered in the hyperuricemia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Hyperuricemia Drugs Market?
2. What is the CAGR expected in the Hyperuricemia Drugs Market?
3. What Are the Key Innovations Transforming the Hyperuricemia Drugs Industry?
4. Which Region Is Leading the Hyperuricemia Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments."
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Hyperuricemia Drugs Market Size To Grow At Arecord 8.2% Cagr By 2029 here
News-ID: 4048703 • Views: …
More Releases from The Business research company
Surge Of Product Developments In Downstream Processing Market Industry Trends Ga …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Downstream Processing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of downstream processing has seen significant growth lately. The projections indicate that its value will rise from $31.26 billion in 2024 to $35.54 billion in 2025, representing a compound annual growth rate…
Major Growth Driver Identified in 2025 Disability Insurance Market: Rising Numbe …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Disability Insurance Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for disability insurance has witnessed a quick ascent lately. It is projected to increase from $4.11 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of…
Surge In Smart Tv Adoption Fuels Growth Of The Digital Tv Soc Market: Critical D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Digital TV SoC Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the Digital TV SoC market has seen substantial growth in the past few years. The market, which was valued at $11.04 billion in 2024, is projected to reach $12.36 billion in…
Diet Pills Market Expansion Continues, with Forecast Valuation of $3.15 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diet Pills Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of diet pills has seen a swift expansion in the past few years. The value is expected to rise from $1.79 billion in 2024 to $1.99 billion in 2025, indicating a compound…
More Releases for Hyperuricemia
Hyperuricemia Drugs Market Size, Share and Growth Report, 2034
" The hyperuricemia drug market is projected to reach a valuation of approximately $7.5 billion in 2024, driven by the rising prevalence of gout and escalating healthcare expenditures. The anticipated market growth for the period from 2025 to 2034 is expected to propel the market value to around $12 billion, reflecting an impressive Compound Annual Growth Rate (CAGR) of 5.4%. "
Exactitude Consultancy., Ltd. released a research report titled "Hyperuricemia Drugs…
Hyperuricemia Drugs Market Forecast 2025-2034: Evaluating Growth Factors, Segmen …
How Are the key drivers contributing to the expansion of the hyperuricemia drugs market?
The hyperuricemia drug market's expansion is likely to be fueled by an increasing prevalence of hyperuricemia and gout. Hyperuricemia refers to the condition in which there is an excessive amount of uric acid in the bloodstream. This condition can lead to the development of gout, an arthritis type that results in debilitating pain due to the accumulation…
What's Driving the Hyperuricemia Drugs Market 2025-2034: Rising Incidence Of Hyp …
What Are the Projections for the Size and Growth Rate of the Hyperuricemia Drugs Market?
The market size of drugs for hyperuricemia has seen robust growth in the past few years. The market is expected to expand from $4.75 billion in 2024 to $5.16 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.5%. The historical growth can be credited to factors such as the escalating cases of gout,…
Hyperuricemia Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals, …
Hyperuricemia companies are LG Chem, Shanton Pharma, InventisBio Co., Ltd, Jiangsu HengRui Medicine Co., Ltd., Fuji Yakuhin Co., Ltd., Virchow Group, Sanofi, Kissei Pharmaceutical Co., Ltd, Getz Pharma, Ardea Biosciences, Inc., Urica Therapeutics Inc., Nuon Therapeutics, Inc., CymaBay Therapeutics, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and others.
(Albany, US) DelveInsight's "Hyperuricemia - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hyperuricemia, historical and forecasted epidemiology as…
Hyperuricemia Market Statistical Forecast, Trade Analysis 2024 - 2031
DataM Intelligence has published a new research report on "Hyperuricemia Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/hyperuricemia-market
The…
Hyperuricemia Drugs Market: Insights and Forecast | 2024-2030
Hyperuricemia Drugs Market Overview:
Maximize Market Research a business Analytics company has released a report on the "Hyperuricemia Drugs Market". As per the "Hyperuricemia Drugs report," the total market size value from 2023 and estimated value for 2030 with a CAGR forecasted from 2024 to 2030.
Projected Growth in Revenue:
The Hyperuricemia Drugs Market size was valued at USD 5.08 Billion in 2023 and the total Hyperuricemia Drugs Market revenue is expected to…
